RosVivo Therapeutics
Kenton M. Sanders is a Scientific Advisors at RosVivo Therapeutics. Kenton is also a Professor at the University of Nevada, Reno School of Medicine.
This person is not in the org chart
RosVivo Therapeutics
1 followers
RosVivo Therapeutics targets diseases with breakthrough therapies utilizing microRNA (miRNA) and small interfering-RNA (siRNA) drugs. They're using unique scientific insights to develop a new pipeline of first-in-class drugs and diagnostic tests. Their development programs focus on the leading T2D, obesity, and COVID-19 drug candidates.